Skip to main content

2020 | OriginalPaper | Buchkapitel

Analyzing the Immune Response of Neoepitopes for Personalized Vaccine Design

verfasst von : Iker Malaina, Leire Legarreta, Mª Dolores Boyano, Santos Alonso, Ildefonso M. De la Fuente, Luis Martinez

Erschienen in: Bioinformatics and Biomedical Engineering

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

In the last few years, the importance of neoepitopes for the development of personalized antitumor vaccines has increased remarkably. This kind of epitopes are considered to generate a strong immune reaction, while their non-mutated version, which sometimes differs only in a single amino-acid, does not generate a response at all. In order to study if, regardless the immune tolerance, neoepitopes are quantitatively more immunogenic than the original strings, we have obtained samples of mutated and non-mutated epitopes of six patients with cutaneous melanoma in different stages, and then we have compared them. More precisely, we have used several bioinformatic tools to study certain properties of the epitopes such as the HLA binding affinity of classes I and II, and found that some of them are in fact increased in their mutated versions, which supports the hypothesis, and also reinforces the use of neoepitopes for cancer vaccine design.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
3.
Zurück zum Zitat Sahin, U., et al.: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 7662 (2017)CrossRef Sahin, U., et al.: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 7662 (2017)CrossRef
4.
Zurück zum Zitat Kakimi, K., Karasaki, T., Matsushita, H., Sugie, T.: Advances in personalized cancer immunotherapy. Breast Cancer 24, 16–24 (2017)CrossRef Kakimi, K., Karasaki, T., Matsushita, H., Sugie, T.: Advances in personalized cancer immunotherapy. Breast Cancer 24, 16–24 (2017)CrossRef
5.
Zurück zum Zitat Stratton, M.R.: Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011)CrossRef Stratton, M.R.: Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011)CrossRef
6.
Zurück zum Zitat Kreiter, S., Castle, J.C., Türeci, Ö., Sahin, U.: Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 1, 768–769 (2012)CrossRef Kreiter, S., Castle, J.C., Türeci, Ö., Sahin, U.: Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 1, 768–769 (2012)CrossRef
7.
Zurück zum Zitat Leclerc, M., et al.: Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front. Immunol. 10, 1505 (2019)CrossRef Leclerc, M., et al.: Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front. Immunol. 10, 1505 (2019)CrossRef
8.
Zurück zum Zitat Vormehr, M., Türeci, Ö., Sahin, U.: Harnessing tumor mutations for truly individualized cancer vaccines. Annu. Rev. Med. 70, 395–407 (2019)CrossRef Vormehr, M., Türeci, Ö., Sahin, U.: Harnessing tumor mutations for truly individualized cancer vaccines. Annu. Rev. Med. 70, 395–407 (2019)CrossRef
9.
Zurück zum Zitat Tanyi, J.L., et al.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Sci. Transl. Med. 10, eaao5931 (2018)CrossRef Tanyi, J.L., et al.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Sci. Transl. Med. 10, eaao5931 (2018)CrossRef
10.
Zurück zum Zitat Hu, Z., Ott, P.A., Wu, C.J.: Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168 (2018)CrossRef Hu, Z., Ott, P.A., Wu, C.J.: Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168 (2018)CrossRef
11.
Zurück zum Zitat Fritsch, E.F., Rajasagi, M., Ott, P.A., Brusic, V., Hacohen, N., Wu, C.J.: HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol. Res. 2, 522–529 (2014)CrossRef Fritsch, E.F., Rajasagi, M., Ott, P.A., Brusic, V., Hacohen, N., Wu, C.J.: HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol. Res. 2, 522–529 (2014)CrossRef
12.
Zurück zum Zitat Lundegaard, C., Lund, O., Nielsen, M.: Prediction of epitopes using neural network-based methods. J. Immunol. Methods 374, 26–34 (2011)CrossRef Lundegaard, C., Lund, O., Nielsen, M.: Prediction of epitopes using neural network-based methods. J. Immunol. Methods 374, 26–34 (2011)CrossRef
13.
Zurück zum Zitat Zhang, Q., et al.: Immune epitope database analysis resource (IEDB-AR). Nucl. Acids Res. 36, 513–518 (2008)CrossRef Zhang, Q., et al.: Immune epitope database analysis resource (IEDB-AR). Nucl. Acids Res. 36, 513–518 (2008)CrossRef
14.
Zurück zum Zitat Soria-Guerra, R.E., Nieto-Gomez, R., Govea-Alonso, D.O., Rosales-Mendoza, S.: An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J. Biomed. Inform. 53, 405–414 (2015)CrossRef Soria-Guerra, R.E., Nieto-Gomez, R., Govea-Alonso, D.O., Rosales-Mendoza, S.: An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J. Biomed. Inform. 53, 405–414 (2015)CrossRef
15.
Zurück zum Zitat Martínez, L., Milanič, M., Malaina, I., Álvarez, C., Pérez, M.B., Ildefonso, M.: Weighted lambda superstrings applied to vaccine design. PLoS ONE 14, e0211714 (2019)CrossRef Martínez, L., Milanič, M., Malaina, I., Álvarez, C., Pérez, M.B., Ildefonso, M.: Weighted lambda superstrings applied to vaccine design. PLoS ONE 14, e0211714 (2019)CrossRef
17.
Zurück zum Zitat Miller, A.J., Mihm, M.C.: Melanoma. N. Engl. J. Med. 355, 51–65 (2006)CrossRef Miller, A.J., Mihm, M.C.: Melanoma. N. Engl. J. Med. 355, 51–65 (2006)CrossRef
18.
Zurück zum Zitat Thompson, J.A.: The revised american joint committee on cancer staging system for melanoma. In: Seminars in Oncology, vol. 29, pp. 361–369. WB Saunders (2002) Thompson, J.A.: The revised american joint committee on cancer staging system for melanoma. In: Seminars in Oncology, vol. 29, pp. 361–369. WB Saunders (2002)
19.
Zurück zum Zitat Edlundh-Rose, E., et al.: NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471–478 (2006)CrossRef Edlundh-Rose, E., et al.: NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471–478 (2006)CrossRef
20.
Zurück zum Zitat Nikolaev, S.I., et al.: Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 44, 133 (2012)CrossRef Nikolaev, S.I., et al.: Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 44, 133 (2012)CrossRef
21.
Zurück zum Zitat Ott, P.A., et al.: An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217 (2017)CrossRef Ott, P.A., et al.: An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217 (2017)CrossRef
22.
Zurück zum Zitat Mann, E.R., Li, X.: Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. WJG 20, 9653 (2014)CrossRef Mann, E.R., Li, X.: Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. WJG 20, 9653 (2014)CrossRef
23.
Zurück zum Zitat Trolle, T., et al.: The length distribution of class I–restricted T cell epitopes is determined by both peptide supply and MHC allele–specific binding preference. J. Immunol. 196, 1480–1487 (2016)CrossRef Trolle, T., et al.: The length distribution of class I–restricted T cell epitopes is determined by both peptide supply and MHC allele–specific binding preference. J. Immunol. 196, 1480–1487 (2016)CrossRef
24.
Zurück zum Zitat López-Martínez, A., Chávez-Muñoz, C., Granados, J.: Función biológica del complejo principal de histocompatibilidad. Revista de investigación clínica 57, 132–141 (2005)PubMed López-Martínez, A., Chávez-Muñoz, C., Granados, J.: Función biológica del complejo principal de histocompatibilidad. Revista de investigación clínica 57, 132–141 (2005)PubMed
25.
Zurück zum Zitat Sette, A., et al.: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586–5592 (1994)PubMed Sette, A., et al.: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586–5592 (1994)PubMed
26.
Zurück zum Zitat Moutaftsi, M., et al.: A consensus epitope prediction approach identifies the breadth of murine T CD8 + -cell responses to vaccinia virus. Nat. Biotechnol. 24, 817 (2006)CrossRef Moutaftsi, M., et al.: A consensus epitope prediction approach identifies the breadth of murine T CD8 + -cell responses to vaccinia virus. Nat. Biotechnol. 24, 817 (2006)CrossRef
27.
Zurück zum Zitat Kotturi, M.F., et al.: The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81, 4928–4940 (2007)CrossRef Kotturi, M.F., et al.: The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81, 4928–4940 (2007)CrossRef
Metadaten
Titel
Analyzing the Immune Response of Neoepitopes for Personalized Vaccine Design
verfasst von
Iker Malaina
Leire Legarreta
Mª Dolores Boyano
Santos Alonso
Ildefonso M. De la Fuente
Luis Martinez
Copyright-Jahr
2020
DOI
https://doi.org/10.1007/978-3-030-45385-5_4